RGS4 Polyclonal Antibody, FITC Conjugated
Product Specifications
Background
Inhibits signal transduction by increasing the GTPase activity of G protein alpha subunits thereby driving them into their inactive GDP-bound form. Activity on G (z) -alpha is inhibited by phosphorylation of the G-protein. Activity on G (z) -alpha and G (i) -alpha-1 is inhibited by palmitoylation of the G-protein.
Synonyms
Regulator of G protein signalling 4; Regulator of G-protein signaling 4; RGP 4; RGP-4; RGS 4; RGS4; RGS4_HUMAN; Schizophrenia disorder 9; SCZD 9; SCZD9; MGC2124; MGC60244.
Gene ID
5999
Host
Rabbit
Cross Reactivity
Human, Mouse, Rat
Immunogen
51-150/205
Target
RGS4
Clonality
Polyclonal
Isotype
IgG
Conjugation
FITC
Source
KLH conjugated synthetic peptide derived from human RGS4
Applications
WB, IF
Purification
Purified by Protein A.
Excitation Emission
494nm/518nm
Concentration
1µg/µl
Dilution
WB (WB=1:500-2000), IF (IF=1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
5999
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUB1801-100 1x 100 µL
ETS1 (Marker of Tumor Metastasis) (ETS1/1801), 0.2mg/mL
Sign In for Pricing
View Details 
HP228271 200 Reactions
VPS26 (VPS26A) Human qPCR Primer Pair (NM_004896)
Sign In for Pricing
View Details 
